Öztürk Ömer, Kaplan Mustafa, Tenlik İlyas, Gökbulut Volkan, Arı Derya, Özin Yasemin
Gastroenterology Clinic, Ankara Bilkent City Hospital, Ankara, Turkey.
Gastroenterology Clinic, Kayseri Memorial Hospital, Kayseri, Turkey.
Eurasian J Med. 2022 Feb;54(1):45-49. doi: 10.5152/eurasianjmed.2022.21127.
We examined the prevalence of esophageal cancer in 828 patients diagnosed with achalasia and the characteristics of patients who developed esophageal cancer.
The demographic characteristics and medical records of the patients who were followed up with a diagnosis of achalasia between 1995 and 2019 were investigated from the patient files.
The mean age of the patients was 51 ± 17.3, 390 of them were males (47.1%) and 438 were females (52.9%). The mean diagnosis age of the patients was 45.4 years. The median follow-up duration of the patients was 73 months (12-480). Esophageal cancer developed in 5 patients (0.6%) during follow-up. Three of these 5 patients had squamous cell carcinoma (60%) and 2 had adenocarcinoma (40%). Three of these patients were males (60%) and 2 were females (40%). The mean age of the patients was 68 (56-78), and cancer developed after a median of 156 months (24-216) after the achalasia diagnosis. Balloon dilation therapy was performed for the treatment of achalasia in all 5 patients who developed esophageal cancer.
Achalasia patients have an increased risk of developing esophageal cancer compared to the general population, and patients should be followed closely for cancer development.
我们研究了828例被诊断为贲门失弛缓症患者的食管癌患病率以及发生食管癌患者的特征。
从患者档案中调查了1995年至2019年间被诊断为贲门失弛缓症并接受随访患者的人口统计学特征和病历。
患者的平均年龄为51±17.3岁,其中390例为男性(47.1%),438例为女性(52.9%)。患者的平均诊断年龄为45.4岁。患者的中位随访时间为73个月(12 - 480个月)。随访期间有5例患者(0.6%)发生了食管癌。这5例患者中3例为鳞状细胞癌(60%),2例为腺癌(40%)。其中3例患者为男性(60%),2例为女性(40%)。患者的平均年龄为68岁(56 - 78岁),癌症在贲门失弛缓症诊断后中位156个月(24 - 216个月)发生。所有5例发生食管癌的患者均接受了球囊扩张治疗贲门失弛缓症。
与普通人群相比,贲门失弛缓症患者发生食管癌的风险增加,应对患者密切随访以防癌症发生。